Dr. Bochner’s research involves the development of gene therapy strategies for the treatment of bladder and prostate cancers. He is evaluating the use of various viral-based systems to deliver therapeutic genes to the bladder and prostate. He is also studying the role of new blood vessel formation (angiogenesis) in the progression of bladder and prostate tumors, with the goal of developing applications of potential anti-angiogenesis therapy.